China    manufacturer

Hangzhou AllTest Biotech CO.,LTD 

      Your Reliable Rapid Test Partner!

Sales & Support
Request A Quote - Email
Select Language
English
French
German
Italian
Russian
Spanish
Portuguese
Dutch
Greek
Japanese
Korean
Arabic
Hindi
Turkish
Indonesian
Vietnamese
Thai
Bengali
Persian
Polish
China good quality Custom Monoclonal Antibody on sale China good quality Hybridoma Monoclonal Antibody on sale
I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

I'm Online Chat Now
Company News

[2020-08-03 18:51:39]
Recent research suggests that obesity, type 2 diabetes, and high blood pressure increase teenagers' risk of premature aging of blood vessels (before age 55 for males and before age 65 for females). Teenagers with any of these three health problems are more likely to develop thicker, stiffer blood ...     Read More

[2020-07-28 18:06:51]
Diagnostic testing key for better classifying and managing the full spectrum of disease. Diagnostic testing could be the linchpin for developing precision prevention, therapeutics, treatments, and prognostics in diabetes, according to an international consensus report. Precision diagnostics in type ...     Read More

[2020-07-20 18:23:26]
Diagnostic testing could be the linchpin for developing precision prevention, therapeutics, treatments, and prognostics in diabetes, according to an international consensus report. Precision diagnostics in type 1 and type 2 diabetes has made a great deal of progress, “but at this stage it remains ...     Read More

[2020-07-06 16:31:47]
LABORATORIANS CAN LEAD A NEW ERA IN RAPID TESTING WITH EXPERTISE IN QUALITY CONTROL AND RESULT INTERPRETATION For those outside of the infectious diseases field, clinical microbiology might conjure an image of microbiologists manipulating petri plates full of bacteria. Although microbiologists still ...     Read More

[2020-06-28 17:21:27]
Rapid results alone not enough to justify devices’ use in emergency settings; higher analytical sensitivity needed to rule out hospitalizations. Simply returning rapid results is not sufficient for implementing point-of-care testing (POCT) for cardiac biomarkers. A review article stresses the need ...     Read More

[2020-06-22 18:06:17]
Emerging evidence suggests neurofilament light chain (NfL) might be important in predicting progression of multiple sclerosis (MS). A study in Neurology reported that MS patients with elevated levels of this nerve protein biomarker were 40% to 70% more likely than those with low levels of NfL to ...     Read More

[2020-06-15 13:33:20]
Diagnostics based on cfDNA could make tissue biopsy obsolete Costly and invasive tissue biopsies to detect allograft rejection after transplantation have numerous limitations. Assays based on cell-free DNA (cfDNA)—circulating fragments of DNA released from cells, tissues, and organs as they undergo ...     Read More

[2020-06-10 14:28:48]
Data paired with education, communication, and relationship-building drive success Controlled substance monitoring and other drug testing give clinicians valuable information about how patients adhere to treatment regimens or might be misusing or even abusing drugs. But keeping up with a continually ...     Read More

[2020-06-01 10:50:29]
Protocol combining hs-cTn measurements, modified HEART score enabled earlier discharge of suspected acute coronary syndrome cases without affecting patients' safety. An approach that combines multiple high-sensitivity cardiac troponin T (hs-cTnT) tests with a modified HEART score shows promise in ...     Read More

[2020-05-25 13:14:44]
All adults age 18 and older should be screened for hepatitis C virus (HCV) infection at least once in their lifetime, while women should be screened during every pregnancy, say new U.S. Centers for Disease Control and Prevention (CDC) recommendations. These latest recommendations, published on April ...     Read More
Page 1 of 20 |< << 1  2  3  4  5  6  7  8  9  10  >> >|